Health

Immune system ‘remembers’ coronavirus for at least 6 months: study

by Kelly MACNAMARA PARIS, France (AFP) -- People may be able to fight off reinfection for at least six months…

World facing ‘catastrophic’ moral failure on vaccines: WHO chief

  GENEVA, Switzerland (AFP) -- The world is on the "brink of a catastrophic moral failure" if rich countries hog…

World migration down 30 percent due to pandemic: UN

  UNITED NATIONS (AFP) -- The coronavirus pandemic has slowed global migration by nearly 30 percent, with around two million…

WHO meeting urges increased virus sequencing to combat variants

by Robin MILLARD Agence France Presse GENEVA, Switzerland (AFP) -- The World Health Organization's emergency committee called Friday for globally-ramped…

More than 2 million COVID-19 deaths worldwide as cases top 93.5 million — Johns Hopkins data

  (Eagle News) -- The total number of COVID-19 deaths worldwide surpassed two million as global confirmed cases reached 93.5…

Climate change worsens child malnutrition: study

by Patrick GALEY Agence France-Presse PARIS, France (AFP) — Climate change may contribute more to greater child malnutrition and poor…

New virus mutation raises vaccine questions

by Paul RICARD PARIS, France (AFP) -- As the British coronavirus variant occupies countries' pandemic plans due to its increased…

British virus variant now in 50 countries, while South African strain found in 20 countries: WHO

by Robin MILLARD Agence France Presse GENEVA, Switzerland (AFP) -- The coronavirus mutation first found in Britain has now spread…

Indonesia okays emergency use of Sinovac, as Turkey announces start of vaccination this week

  (Eagle News) -- Indonesia has given emergency use approval to the COVID-19 vaccine developed by China’s Sinovac BioTech Ltd.,…

Sinovac’s CoronaVac vaccine 78% effective in final stage clinical trials in Brazil, says officials

  SAO PAULO, Brazil (AFP) -- Chinese-developed Covid-19 vaccine CoronaVac showed at least 78-percent effectiveness in final-stage clinical trials in…

This website uses cookies.